Anbio Biotechnology (NASDAQ:NNNN) Stock Price Down 8.4% – Should You Sell?

Anbio Biotechnology (NASDAQ:NNNN) shares fell 8.4% during trading on Thursday . The company traded as low as $28.71 and last traded at $29.1520. 13,798 shares traded hands during trading, a decline of 69% from the average session volume of 45,140 shares. The stock had previously closed at $31.84.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Anbio Biotechnology currently has an average rating of “Hold”.

Anbio Biotechnology Stock Down 5.0%

The business’s 50 day moving average price is $25.83.

Anbio Biotechnology (NASDAQ:NNNN) last issued its earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.